ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Immune Design Corp Delisted | IMDZ | United States of America | — | 2 |
| Vincerx Pharma, Inc. Common Stock | VINC | United States of America | — | 2 |
| Amarin Corp PLC Delisted | — | United Kingdom | — | 1 |
| Idogen AB Delisted | IDOGEN | Sweden | — | 1 |
| Lipella Pharmaceuticals Inc. Common Stock | LIPO | United States of America | — | 1 |
| Redwood Pharma AB Delisted | REDW | Sweden | — | 1 |
| Seelos Therapeutics, Inc. | SEELQ | United States of America | — | 1 |
| Accentia Biopharmaceuticals Inc Delisted | ABPI | United States of America | — | 0 |
| Advaxis Inc. Wt Exp 07/15/2018 Delisted | ADXSW | United States of America | — | 0 |
| Agi Therapeutics Delisted | — | Ireland | — | 0 |
| Allarity Therapeutics A/S Delisted | ALLR | Denmark | — | 0 |
| Alligator Bioscience BTU Delisted | ATORX-BTU | Sweden | — | 0 |
| Amniotics AB Delisted | AMNI | Sweden | — | 0 |
| Angion Biomedica Corp. Common Stock Delisted | ANGN_old | United States of America | — | 0 |
| Antisoma Delisted | — | United Kingdom | — | 0 |
| Apexigen Inc. Delisted | APGN | United States of America | — | 0 |
| Arana Therapeutics LTD Delisted | — | Australia | — | 0 |
| Arcede Pharma AB Delisted | ARCEDE | Sweden | — | 0 |
| ARYA Sciences Acquisition Corp II Delisted | ARYB | Cayman Islands | — | 0 |
| BioPharmX Corporation Delisted | BPMX | United States of America | — | 0 |
| BioTime Inc. Wt Exp 10/01/2018 Delisted | BTX-WS | United States of America | — | 0 |
| Brickell Biotech Inc Delisted | BBI | United States of America | — | 0 |
| Cantab Pharmaceuticals Delisted | — | United Kingdom | — | 0 |
| Cassiopea SpA Delisted | SKIN | Italy | — | 0 |
| Cenes Pharmaceuticals Delisted | — | United Kingdom | — | 0 |
| Clarmin Explorations Inc Delisted | CX | Canada | — | 0 |
| Cline Scientific AB Series B Delisted | CLINE-B | Sweden | — | 0 |
| CoLucid Pharmaceuticals Inc Delisted | CLCD | United States of America | — | 0 |
| ContraFect Corp Wt Cl A Exp 01/31/2017 Delisted | CFRXW | United States of America | — | 0 |
| ContraFect Corp Wt Cl B Exp 10/31/2015 Delisted | CFRXZ | United States of America | — | 0 |
| Curative Biotechnology Inc | CUBT | United States of America | — | 0 |
| Cuspis Capital III Ltd. Delisted | CIII-P | Canada | — | 0 |
| Cytori Therapeutics Inc. WT S EXP 052820 Delisted | CYTXZ | United States of America | — | 0 |
| Denali Capital Acquisition Corp. Class A Ordinary Shares Delisted | DECA | Cayman Islands | — | 0 |
| Ectin Research AB | ECTIN B | Sweden | — | 0 |
| Effector Therapeutics Inc | EFTR | United States of America | — | 0 |
| European Biotech Acquisition Corp Delisted | EBAC | Cayman Islands | — | 0 |
| Evolutec Group Delisted | — | United Kingdom | — | 0 |
| Field Trip Health Ltd Delisted | FTRP | Canada | — | 0 |
| FIT Biotech Oy Delisted | FITBIO | Finland | — | 0 |
| Follicum AB Delisted | FOLLI | Sweden | — | 0 |
| FStar Therapeutics Inc Delisted | FSTX | United States of America | — | 0 |
| GTx Inc Delisted | GTXI | United States of America | — | 0 |
| Human Stem Cells Institute PJSC | ISKJ | Russian Federation | — | 0 |
| Intercytex Group Delisted | — | United Kingdom | — | 0 |
| ISR Immune System Regulation Holding AB Delisted | ISR | Sweden | — | 0 |
| K.S.Biomedix Hldgs Delisted | — | United Kingdom | — | 0 |
| Longevity Acquisition Corporation Delisted | LOAC | Virgin Islands (British) | — | 0 |
| MGC Pharmaceuticals Limited Delisted | MXC | United Kingdom | — | 0 |
| Napo Pharmaceuticals Inc Delisted | — | United Kingdom | — | 0 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.